Comparison of Alfredson and Silbernagel Protocol in Competitive Athletes With Achilles Tendinopathy

Launched by CHARLES UNIVERSITY, CZECH REPUBLIC · Dec 12, 2022

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • Athletes performing track and field, tennis or football at the competitive level
• • Age 18 to 40 years
• • Unilateral Achilles tendinopathy
• • Pain lasting more than 2 months
• • Diagnosis of Achilles tendinopathy established by pain on function at the Achilles region and ultrasound assessment (tendon thickening, swollen tendon) by one researcher
• • Participants trained at least 3 times per week before the onset of Achilles tendinopathy
• • Less than 3 months without training and less than 6 months from the last competition/match
• • Wish to return to original sport level
• • Willing to stop with other treatments 2 weeks before the start of the clinical trial
• Exclusion criteria:
• • Achilles tendon rupture in past
• • Corticosteroid injection in Achilles tendon region in last 6 months
• • Having other lower limb musculoskeletal injuries or surgery in the last 6 months (e.g., muscle rupture, bone fracture)
• • Having a neurological, systemic or autoimmune disease (e.g., neuropathy, type 1 diabetes, rheumatoid arthritis)